We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.1B
AUM Growth
+$407M
Cap. Flow
-$92.2M
Cap. Flow %
-1.3%
Top 10 Hldgs %
23.68%
Holding
2,973
New
384
Increased
1,273
Reduced
905
Closed
264

Sector Composition

Rank Sector Weight
1 Technology 22.98%
2 Consumer Discretionary 12.04%
3 Financials 12.03%
4 Healthcare 11.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HONE
2026
DELISTED
HarborOne Bancorp
HONE
$191K ﹤0.01%
13,289
+2,286
+21% +$33K
TVRD
2027
Tvardi Therapeutics
TVRD
$22.1M
$190K ﹤0.01%
370
+13
+4% +$8.24K
TRST
2028
Trustco Bank Corp NY
TRST
$971M
$190K ﹤0.01%
5,526
+1,668
+43% +$61.7K
CENX icon
2029
Century Aluminum
CENX
$4.59B
$190K ﹤0.01%
14,733
+1,679
+13% +$24.2K
RMAX icon
2030
RE/MAX Holdings
RMAX
$265M
$190K ﹤0.01%
5,690
VBIV
2031
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$189K ﹤0.01%
1,882
+112
+6% +$10.9K
MTUS icon
2032
Metallus
MTUS
$892M
$189K ﹤0.01%
13,362
+2,085
+18% +$28.2K
YORW icon
2033
York Water
YORW
$536M
$189K ﹤0.01%
4,173
+330
+9% +$16.4K
STOK icon
2034
Stoke Therapeutics
STOK
$2.02B
$189K ﹤0.01%
5,614
+1,834
+49% +$64.8K
PETS icon
2035
PetMed Express
PETS
$43.4M
$189K ﹤0.01%
5,924
+31
+0.5% +$985
AERI
2036
DELISTED
Aerie Pharmaceuticals
AERI
$189K ﹤0.01%
11,782
+712
+6% +$12.2K
QS icon
2037
QuantumScape Corp
QS
$3.79B
$188K ﹤0.01%
+6,436
New +$208K
NRC icon
2038
NRC Health Common Stock
NRC
$471M
$188K ﹤0.01%
4,091
TRTX
2039
TPG RE Finance Trust
TRTX
$616M
$188K ﹤0.01%
13,941
-3,757
-21% -$48.1K
OPEN icon
2040
Opendoor
OPEN
$3.54B
$187K ﹤0.01%
+10,908
New +$187K
DGII icon
2041
Digi International
DGII
$3.23B
$187K ﹤0.01%
9,306
+1,618
+21% +$30.4K
AKRO
2042
DELISTED
Akero Therapeutics
AKRO
$187K ﹤0.01%
7,526
+3,666
+95% +$103K
VVX icon
2043
V2X
VVX
$2.55B
$187K ﹤0.01%
3,922
KRNY icon
2044
Kearny Financial
KRNY
$604M
$187K ﹤0.01%
15,608
-5,088
-25% -$64.3K
PAHC icon
2045
Phibro Animal Health
PAHC
$1.38B
$186K ﹤0.01%
6,456
ETD icon
2046
Ethan Allen Interiors
ETD
$583M
$186K ﹤0.01%
6,747
-56
-0.8% -$1.62K
MSBI icon
2047
Midland States Bancorp
MSBI
$698M
$186K ﹤0.01%
7,086
CLAR icon
2048
Clarus
CLAR
$145M
$185K ﹤0.01%
7,198
+4
+0.1% +$85
XENT
2049
DELISTED
Intersect ENT, Inc
XENT
$184K ﹤0.01%
10,790
+1,753
+19% +$32.8K
VST icon
2050
Vistra
VST
$49.1B
$184K ﹤0.01%
9,907
+25
+0.3% +$432

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 Portfolio in Review

As of Q2 2021, Metropolitan Life Insurance Company (MetLife) held 2,973 positions worth $7.1B, up 6.1% from $6.69B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q2 2021 filing shows 384 new, 1,273 increased, 905 reduced and 264 closed positions. Its largest new stake was Palantir: 112,538 shares worth $2.97M. The largest sale was Alphabet (Google) Class C, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q2 2021 buy was Palantir: 112,538 shares worth $2.97M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $33.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $16M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alphabet (Google) Class C in Q2 2021, selling an estimated $96.8M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $7.1B portfolio in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 384 new positions and closed 264 in Q2 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.1% quarter-over-quarter to $7.1B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2021, filed 16 Aug 2021.